These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. CSF biomarkers and amyloid PET: concordance and diagnostic accuracy in a MCI cohort. Spallazzi M; Barocco F; Michelini G; Immovilli P; Taga A; Morelli N; Ruffini L; Caffarra P Acta Neurol Belg; 2019 Sep; 119(3):445-452. PubMed ID: 30847669 [TBL] [Abstract][Full Text] [Related]
47. Discordant amyloid-β PET and CSF biomarkers and its clinical consequences. de Wilde A; Reimand J; Teunissen CE; Zwan M; Windhorst AD; Boellaard R; van der Flier WM; Scheltens P; van Berckel BNM; Bouwman F; Ossenkoppele R Alzheimers Res Ther; 2019 Sep; 11(1):78. PubMed ID: 31511058 [TBL] [Abstract][Full Text] [Related]
48. 18F-Flortaucipir PET Associations with Cerebrospinal Fluid, Cognition, and Neuroimaging in Mild Cognitive Impairment due to Alzheimer's Disease. Okafor M; Nye JA; Shokouhi M; Shaw LM; Goldstein F; Hajjar I J Alzheimers Dis; 2020; 74(2):589-601. PubMed ID: 32065800 [TBL] [Abstract][Full Text] [Related]
49. Temporal Dynamics of β-Amyloid Accumulation in Aging and Alzheimer Disease. Jagust WJ; Landau SM; Neurology; 2021 Mar; 96(9):e1347-e1357. PubMed ID: 33408147 [TBL] [Abstract][Full Text] [Related]
50. The combination of apolipoprotein E4, age and Alzheimer's Disease Assessment Scale - Cognitive Subscale improves the prediction of amyloid positron emission tomography status in clinically diagnosed mild cognitive impairment. Ba M; Ng KP; Gao X; Kong M; Guan L; Yu L; Eur J Neurol; 2019 May; 26(5):733-e53. PubMed ID: 30561868 [TBL] [Abstract][Full Text] [Related]
51. Executive and Language Subjective Cognitive Decline Complaints Discriminate Preclinical Alzheimer's Disease from Normal Aging. Valech N; Tort-Merino A; Coll-Padrós N; Olives J; León M; Rami L; Molinuevo JL J Alzheimers Dis; 2018; 61(2):689-703. PubMed ID: 29254090 [TBL] [Abstract][Full Text] [Related]
53. Associations between tau, Aβ, and cortical thickness with cognition in Alzheimer disease. Ossenkoppele R; Smith R; Ohlsson T; Strandberg O; Mattsson N; Insel PS; Palmqvist S; Hansson O Neurology; 2019 Feb; 92(6):e601-e612. PubMed ID: 30626656 [TBL] [Abstract][Full Text] [Related]
54. Self-reported confusion is related to global and regional β-amyloid: data from the Women's healthy ageing project. McCluskey GE; Yates P; Villemagne VL; Rowe C; Szoeke CEI Brain Imaging Behav; 2018 Feb; 12(1):78-86. PubMed ID: 28108945 [TBL] [Abstract][Full Text] [Related]
55. Biomarker-Based Prediction of Longitudinal Tau Positron Emission Tomography in Alzheimer Disease. Leuzy A; Smith R; Cullen NC; Strandberg O; Vogel JW; Binette AP; Borroni E; Janelidze S; Ohlsson T; Jögi J; Ossenkoppele R; Palmqvist S; Mattsson-Carlgren N; Klein G; Stomrud E; Hansson O JAMA Neurol; 2022 Feb; 79(2):149-158. PubMed ID: 34928318 [TBL] [Abstract][Full Text] [Related]
56. Episodic Memory and Learning Dysfunction Over an 18-Month Period in Preclinical and Prodromal Alzheimer's Disease. Baker JE; Lim YY; Jaeger J; Ames D; Lautenschlager NT; Robertson J; Pietrzak RH; Snyder PJ; Villemagne VL; Rowe CC; Masters CL; Maruff P J Alzheimers Dis; 2018; 65(3):977-988. PubMed ID: 30103330 [TBL] [Abstract][Full Text] [Related]
57. Baseline cognition is the best predictor of 4-year cognitive change in cognitively intact older adults. Schaeverbeke JM; Gabel S; Meersmans K; Luckett ES; De Meyer S; Adamczuk K; Nelissen N; Goovaerts V; Radwan A; Sunaert S; Dupont P; Van Laere K; Vandenberghe R Alzheimers Res Ther; 2021 Apr; 13(1):75. PubMed ID: 33827690 [TBL] [Abstract][Full Text] [Related]
58. Which Episodic Memory Performance is Associated with Alzheimer's Disease Biomarkers in Elderly Cognitive Complainers? Evidence from a Longitudinal Observational Study with Four Episodic Memory Tests (Insight-PreAD). Gagliardi G; Epelbaum S; Houot M; Bakardjian H; Boukadida L; Revillon M; Dubois B; Dalla Barba G; La Corte V; J Alzheimers Dis; 2019; 70(3):811-824. PubMed ID: 31282413 [TBL] [Abstract][Full Text] [Related]